Dr. Bobby Lazzara discusses the first description of reversal of cognitive decline in early Alzheimer disease or its precursors.
Can cognitive decline in early Alzheimer disease or its precursors be reversed? In this Medical News Minute, developed exclusively for Neurology Times, Dr. Bobby Lazzara reviews a small study of ten patients treated with a programmatic and personalized therapeutic approach – metabolic enhancement for neurodegeneration (MEND).
